|
Daniel Moro was Vice President Polymer Drug Delivery at Access Pharmaceuticals from September 2000 until October 2005. He managed various drug delivery projects related to Hydrogel polymers. He invented and helped to commercialize the mucoadhesive erodible drug delivery technology (OraDisc™) for the controlled administration of actives acquired by ULURU Inc. Previously Mr. Moro served as Vice President Operations for a Division of National Patent Development Corporation (NPDC) which developed the soft contact lens. Prior to his operational experience Mr. Moro spent 20 years at the NPDC as a senior research scientist and invented and commercialized several technologies including a hydrogel burn and wound dressing and a subcutaneous retrievable drug delivery implant to treat prostate cancer. This latter technology a one year implant has recently been approved by the FDA and sold under the trademark Vantas. Mr. Moro has over twenty five years experience of pharmaceutical development and holds nine patents related to drug delivery applications four of which have been commercialized. | 